| 000 | 01655 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517133341.0 | ||
| 264 | 0 | _c20180227 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1872-7654 | ||
| 024 | 7 |
_a10.1016/j.ejogrb.2016.11.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSayyah-Melli, M | |
| 245 | 0 | 0 |
_aComparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial. _h[electronic resource] |
| 260 |
_bEuropean journal of obstetrics, gynecology, and reproductive biology _cMar 2017 |
||
| 300 |
_a257-264 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aCabergoline |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aErgolines _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeiomyoma _xdrug therapy |
| 650 | 0 | 4 | _aLetrozole |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitriles _xadministration & dosage |
| 650 | 0 | 4 |
_aTriazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aUterine Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aUterus _xdrug effects |
| 700 | 1 | _aMobasseri, M | |
| 700 | 1 | _aGharabaghi, P M | |
| 700 | 1 | _aOuladsahebmadarek, E | |
| 700 | 1 | _aRahmani, V | |
| 773 | 0 |
_tEuropean journal of obstetrics, gynecology, and reproductive biology _gvol. 210 _gp. 257-264 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejogrb.2016.11.001 _zAvailable from publisher's website |
| 999 |
_c26774326 _d26774326 |
||